Seiichi Ishida,
Guest Researcher, National Institute of Health Sciences, Professor,
Sojo University
Seiichi Ishida has been Professor of Division of Applied Life Science, Graduate School of Engineering, Sojo University, and Guest Researcher of Biological Safety Research Centre at National Institute of Health Sciences since 2020. He received his PhD in Pharmaceutical Science from the University of Tokyo, Japan in 1993, and conducted postdoctoral studies at The Cancer Institute (Tokyo) and at Howard Hughes Medical Institute at Duke University Medical Centre. He used to be Senior Researcher (2000-2007) and Section Chief (2007-2020) of Division of Pharmacology at National Institute of Health Sciences. His research focuses primarily on the development of in vitro cell assay platform for the evaluation of drug metabolism and drug induced liver injury and their application to the regulatory science field.
Research and Development of Microphysiological Systems in Japan Supported by the AMED-MPS Project
Friday, 7 October 2022 at 15:00
Add to Calendar ▼2022-10-07 15:00:002022-10-07 16:00:00Europe/LondonResearch and Development of Microphysiological Systems in Japan Supported by the AMED-MPS Project3D-Bioprinting, Biofabrication, Organoids and Organs-on-Chips Asia 2022 in Tokyo, JapanTokyo, JapanSELECTBIOenquiries@selectbiosciences.com
Microphysiological Systems (MPS) is expected to be novel humanized in vitro test methods that addresses the unmet needs for new drug development. In Japan, the AMED-MPS project is being promoted under the leadership of AMED (the Japan Agency for Medical Research and Development) and Ministry of Economy, Trade and Industry(1). In this project, along with the development of Japan-original MPS for commercialization, there have been discussions on the technical requirements that need to be solved for MPS to be implemented in industry. Stakeholders from academia developers, suppliers of MPS, users of pharmaceutical industry, and the regulatory section are participating in these discussions actively. In this presentation, firstly the development status of Japan-original MPS will be introduced. And, secondly, we would like to present and discuss the concept of "technical requirements for industrial implementation of MPS" from the viewpoint of regulatory science based on the discussions in AMED-MPS project by showing how to establish “Context of Use” from unmet needs that MPS is required to solve and how to promote standardization of MPS. (1) Seiichi Ishida: Research and Development of Microphysiological Systems in Japan Supported by the AMED-MPS Project. Front. Toxicol. doi: 10.3389/ftox.2021.657765
Add to Calendar ▼2022-10-06 00:00:002022-10-07 00:00:00Europe/London3D-Bioprinting, Biofabrication, Organoids and Organs-on-Chips Asia 20223D-Bioprinting, Biofabrication, Organoids and Organs-on-Chips Asia 2022 in Tokyo, JapanTokyo, JapanSELECTBIOenquiries@selectbiosciences.com
Add to Calendar ▼2022-10-07 15:00:002022-10-07 16:00:00Europe/LondonResearch and Development of Microphysiological Systems in Japan Supported by the AMED-MPS Project3D-Bioprinting, Biofabrication, Organoids and Organs-on-Chips Asia 2022 in Tokyo, JapanTokyo, JapanSELECTBIOenquiries@selectbiosciences.com
